Allergy Therapeutics plc (LON:AGY - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 7.50 ($0.09) and last traded at GBX 7.20 ($0.09), with a volume of 2510080 shares trading hands. The stock had previously closed at GBX 7 ($0.09).
Allergy Therapeutics Price Performance
The company has a 50 day moving average of GBX 5.79 and a 200 day moving average of GBX 5.14. The company has a debt-to-equity ratio of 37.22, a quick ratio of 1.48 and a current ratio of 1.40. The stock has a market capitalization of £343.44 million, a price-to-earnings ratio of -120.00, a PEG ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Stories
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
